We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $156B
1-Year Est. Return 27.51%
This Fund
S&P 500
This Quarter Est. Return
+0.65%
1 Year Est. Return
+27.51%
3 Year Est. Return
+75.53%
5 Year Est. Return
+102.92%
10 Year Est. Return
+480.97%
AUM
$45.8B
AUM Growth
-$1.67B
Cap. Flow
-$2.56B
Cap. Flow %
-5.59%
Top 10 Hldgs %
6.8%
Holding
1,994
New
177
Increased
787
Reduced
718
Closed
189

Top Sells

Rank Stock Value
1
VFC icon
VF Corp
VFC
+$164M
2
ODFL icon
Old Dominion Freight Line
ODFL
+$128M
3
A icon
Agilent Technologies
A
+$127M
4
AVY icon
Avery Dennison
AVY
+$120M
5
AFL icon
Aflac
AFL
+$106M

Sector Composition

Rank Sector Weight
1 Financials 19.36%
2 Industrials 14.33%
3 Technology 14.05%
4 Consumer Discretionary 11.58%
5 Healthcare 9.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADMS
1751
DELISTED
Adamas Pharmaceuticals
ADMS
$20K ﹤0.01%
845
TTSH
1752
DELISTED
Tile Shop Holdings
TTSH
$19K ﹤0.01%
3,187
-6,897
-68% -$53.4K
CONE
1753
DELISTED
CyrusOne Inc Common Stock
CONE
$19K ﹤0.01%
375
-31,850
-99% -$1.71M
OLBK
1754
DELISTED
Old Line Bancshares, Inc.
OLBK
$19K ﹤0.01%
578
-4
-0.7% -$127
OMER icon
1755
Omeros
OMER
$952M
$18K ﹤0.01%
1,570
FOMX
1756
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$18K ﹤0.01%
3,583
AGEN
1757
Agenus
AGEN
$312M
$17K ﹤0.01%
188
SKT icon
1758
Tanger
SKT
$4.52B
$17K ﹤0.01%
765
LCNB icon
1759
LCNB Corp
LCNB
$285M
$16K ﹤0.01%
858
-7
-0.8% -$137
BG icon
1760
Bunge Global
BG
$20.9B
$14K ﹤0.01%
190
-16,599
-99% -$1.25M
JNCE
1761
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$14K ﹤0.01%
+610
New +$13.5K
ABEO icon
1762
Abeona Therapeutics
ABEO
$393M
$13K ﹤0.01%
+37
New +$13.7K
PDFS icon
1763
PDF Solutions
PDFS
$1.92B
$13K ﹤0.01%
1,078
-8,546
-89% -$114K
ACAD icon
1764
Acadia Pharmaceuticals
ACAD
$4.9B
$12K ﹤0.01%
513
XLI icon
1765
State Street Industrial Select Sector SPDR ETF
XLI
$33.6B
$12K ﹤0.01%
155
TLGT
1766
DELISTED
Teligent, Inc
TLGT
$11K ﹤0.01%
331
KDNY
1767
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$10K ﹤0.01%
210
CDTX
1768
DELISTED
Cidara Therapeutics
CDTX
$9K ﹤0.01%
110
ADXS
1769
DELISTED
Advaxis Inc
ADXS
$9K ﹤0.01%
354
WPG
1770
DELISTED
Washington Prime Group Inc.
WPG
$7K ﹤0.01%
114
UE icon
1771
Urban Edge Properties
UE
$2.71B
$5K ﹤0.01%
237
-477,030
-100% -$10.7M
IWM icon
1772
iShares Russell 2000 ETF
IWM
$82.1B
$2K ﹤0.01%
12
-33
-73% -$5.1K
IWR icon
1773
iShares Russell Mid-Cap ETF
IWR
$56.7B
$2K ﹤0.01%
32
-96
-75% -$5.06K
ACWI icon
1774
iShares MSCI ACWI ETF
ACWI
$33.3B
-4,824
Closed -$348K
AEHR icon
1775
Aehr Test Systems
AEHR
$3.25B
-444,200
Closed -$1.2M

Similar funds

Victory Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Victory Capital Management held 1,994 positions worth $45.8B, down 3.5% from $47.5B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.

Victory Capital Management withdrew a net $2.56B in Q1 2018, closing 189 positions and reducing 718 holdings. Its most notable exit was Wells Fargo 7.5% Non Cumv Perp Conv, an estimated $64.4M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.

Against the trend, Victory Capital Management opened a new position in Steris worth $114M.

  • Victory Capital Management's largest Q1 2018 buy was Steris: 1,225,800 shares worth $114M.
  • Victory Capital Management added most to Kroger in Q1 2018, an estimated $227M increase.
  • Victory Capital Management's biggest Q1 2018 reduction was VF Corp, cutting an estimated $164M.
  • Victory Capital Management fully exited Wells Fargo 7.5% Non Cumv Perp Conv in Q1 2018, selling an estimated $64.4M.
  • Victory Capital Management's ten largest holdings make up 6.8% of its $45.8B portfolio in Q1 2018.
  • Victory Capital Management opened 177 new positions and closed 189 in Q1 2018.
  • Victory Capital Management's portfolio value fell 3.5% quarter-over-quarter to $45.8B.

Based on Victory Capital Management's 13F filing for Q1 2018, filed 4 May 2018.